Trial record 1 of 10 for:    cerulean
Previous Study | Return to List | Next Study

CRLX101 Plus Bevacizumab in Advanced RCC

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01625936
First received: June 20, 2012
Last updated: May 9, 2016
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)